Search

Objectives and Methods: Incidence, mortality and long-term survival from prostate cancer were examined in the Umbria region of Italy, for the period 1978-1994. Incidence rates were derived from an ad hoc survey carried out over the period 1978-1982 and from 1994 cancer registry records. The mortality over the period derived from data of the official publications and the survival rates, at 15 years, were calculated starting from the ad hoc survey incident cases., Results: In the Umbria region, over the period 1978-1994, crude incidence rates from prostate cancer increased from 31.2 to 81. 9 per 100,000 and mortality rates from 22.7 to 31.9 per 100,000. The rates were from 30.5 to 61.2 for age-adjusted incidence while standardized mortality remained constant (from 22.6 to 22.7 per 100, 000). Survival in Umbria, compared with rates from other European Cancer Registries, is low both at 5- and 10-year follow-up., Conclusion: The great incidence increase observed over the study period could depend on a lesser completeness achieved by the 1978-1982 ad hoc survey with respect to the 1994 cancer registry data and/or from the screening campaign carried out in a large part of the region in 1994. Different elements support these hypotheses. However the above hypotheses can be verified over the next years when further incidence and survival data from the cancer registry will be available.

The aim of this work was to make a study of the whole population of a central Italian region, the Umbria region--cancer survival rates for the upper aerodigestive tract, which includes cancers of the head and neck (tongue, oral cavity, pharynx), oesophagus and larynx. In Italy cancer survival rates do not cover entire regions but single municipalities or provinces. Cases of incidence were derived from an 'ad hoc' survey carried out during the period 1978-1982. Starting from the nominative data, we studied up to 15 years 245 head and neck, 87 oesophagus and 321 larynx cases of cancer in males. Data for female cases were not considered because of the small number. Cancer cases were followed up mainly by verification at the Registry Office of several municipalities, the Regional Death Registry and the list of persons under the Regional Health Service. Observed survival rates for head and neck cancer were 0.63, 0.29, 0.17 and 0.12 at 1, 5, 10 and 15 years of follow-up respectively; rates for cancers of the oesophagus and larynx were 0.30, 0.08, 0.06, 0.03 and 0.79, 0.54, 0.41, 0.30 respectively. Relative survival rates were 0.65, 0.34, 0.24, 0.23 for cancer of the head and neck, 0.31, 0.10, 0.09, 0.08 for cancer of the oesophagus, and 0.81, 0.63, 0.59, 0.56 for cancer of the larynx, at 1, 5, 10 and 15 years of follow-up. The worst survival rates were observed for oesophagus and hypopharynx. Overall survival values for Umbrian patients were relatively good, being higher than survival data reported for a similar period by Italian Cancer Registries. They were also strikingly similar to survival rates for England and Scotland.

Objectives and Methods: Survival of 687 urinary bladder and 217 kidney cancer patients was investigated using incident cases registered in an ad hoc survey in the Umbria region for the period 1978-1982. Death certificate only cases were excluded. The follow-up was carried out through the General Nominative Register of Causes of Death and verified at the Registrar's Offices of the various towns of the Region., Results: At 10 years about one third of all bladder cancer patients were still alive while for kidney cancer the rate was 0.41 for females and 0.26 for males. Observed survival rates, at 1 year time intervals, never differed significantly in the two sexes even if, for kidney cancer, both observed and relative survival rates were somewhat higher in females than in males and, for bladder cancer, higher in males than in females. From survival rates by age groups both observed and relative rates decreased with age in males. In females the trend was unsteady due to the low survival in the first age group (15-44 years) for the two sites and a lower rate for kidney cancers in the 55-64 years age group compared to the next age groups. This trend was also probably due to the small number of cases., Conclusions: Comparison of survivals in Umbria with those of European registries shows higher rates for bladder cancer in both sexes and for kidney cancer in females in Umbria, while the value for kidney cancer survival in males was intermediate.